News

January, 2010. Denver - ValveXchange Inc. is pleased to announce that it has received a $250,000 grant from the State of Colorado under the Bioscience Discovery Evaluation Grant Program (BDEGP). Read More.

News in 2009

November 19, 2009. AURORA – ValveXchange Inc. recently executed a license agreement with the University of Colorado for a process to transform cardiac imaging data into high-quality three-dimensional models used for heart valve product development, clinician training, and pre-procedure planning. Read More.

October, 2009. Denver – ValveXchange Inc. is pleased to announce that Dr. Antonio Calafiore has joined the VXi Medical Advisory Board. Dr. Calafiore is recognized internationally for pioneering off-pump coronary artery bypass grafting and the “Calafiore technique” of myocardial preservation. Dr. Calafiore has recently moved from Italy to Riyadh, Saudi Arabia as the director of the Prince Sultan Cardiac Center. Read More.

September, 2009. Denver – ValveXchange Inc. is pleased to announce that Michael J. Mack, M.D., has joined the VXi Medical Advisory Board. Dr. Mack is Director of Cardiovascular Research and Cardiovascular Medicine of the Heart Hospital Baylor Plano and Director of Cardiovascular Surgery for the Baylor Healthcare System. He is considered to be the most noted authority on the emerging field of transcatheter valves. Read More.

June, 2009. Denver – ValveXchange Inc. announces that Walter Randolph “Randy” Chitwood, Jr., M.D., FACS, FRCS has joined the VXi Medical Advisory Board. Dr. Chitwood was the principal investigator of the FDA robotic mitral valve trials that led to approval for this use in the United States. Today, he is the world’s leader in robotic mitral valve surgery. Read More.

May 15, 2009. Denver - ValveXchange Inc. is pleased to announce that it has signed an option agreement with Dr. Gerard Guiraudon to license his Universal Cardiac Introducer technology. Unlike rigid trocars, the Guiraudon Universal Cardiac Introducer (GUCI) is a flexible, collapsible system that facilitates intracardiac surgery and off-pump exchange of the VXi valve. Read More.

March 18, 2009. San Francisco, CA – Frost and Sullivan held their annual “Excellence in Medical Technologies & Life Sciences Awards” banquet on this date, honoring companies in the bioscience and medical device fields. ValveXchange Chairman and CEO, Larry Blankenship, was there to accept the award. Read More.

March, 2009. Denver – ValveXchange Inc. announced that Dr. Tirone E. David has joined the VXi Medical Advisory Board. Dr. David is recognized world-wide for his pioneering work in valve sparing surgery, his remarkable surgical skills and his commitment to teaching. Read More.

March 30, 2009. Denver - ValveXchange licensed its exchangeable valve technology patents from the Cleveland Clinic. The Clinic and ValveXchange have now entered into an arrangement whereby the Cleveland Clinic will in the future receive an equity position in ValveXchange, Inc. Read More.

February, 2009. Denver - ValveXchange Inc. announced that it is the recipient of the 2009 North American Frost & Sullivan Technology Innovation of the Year Award. According to Frost & Sullivan Research Analyst S.R. Priya, "The ValveXchange Heart Valve System represents a safe and less invasive alternative to conventional therapies.... Overall, the ValveXchange system provides the innate hemodynamic and non-thrombogenic benefits of tissue valves to patients of all ages, thus obviating the need for expensive and potentially problematic anti-coagulation therapies and major lifestyle modifications.” concludes Priya.

February, 2009. Denver - ValveXchange Inc. announced that of Dr. Joseph Sabik, Chair of Cardiothoracic Surgery, The Cleveland Clinic Foundation, will serve as the Chair of the VXi Medical Advisory Board. Read More.

January 30, 2009. Denver - ValveXchange Inc. announced that it has begun animal testing of its proprietary exchangeable valve technology, working with the College of Veterinary Medicine at the Colorado State University, Fort Collins, CO, and with Experimental Surgical Services, University of Minnesota, Minneapolis, MN. Both Institutions are well-recognized for their expertise in animal surgery. Read More.

TOP

News in 2008

November, 2008. Denver – Dr. Floyd Loop, former CEO of The Cleveland Clinic Foundation, has joined the Board of Directors of ValveXchange Inc., and will also chair the Medical Advisory Board. Read More.

October 23, 2008. Denver - Aurora-based medical device has recently been featured in an article posted by the RockyRadar, a local medical device industry newsletter. The review of the ValveXchange approach is one in a series of short stories about start-up companies in the Denver-Boulder area, primarily in the areas of Life Sciences, Information Technologies and Clean Energy. Read More.

October 13, 2008. DENVER—Aurora-based medical device company ValveXchange Inc. announced today that it has been awarded a European patent (EP1,671,608) entitled Cardiovascular Valve Assembly, authored by Dr. Ivan Vesely, the company’s Founder and Chief Scientific Officer. Read More.

July 29, 2008. DENVER—Aurora-based medical device company ValveXchange Inc. announced today that they have received a $1.6 million grant from the National Institutes of Health (NIH) for funding under the SBIR Program related to research and development of its proprietary two-piece heart valve technology. Read More.

January 1, 2008. ValveXchange Inc. is a featured company in Start-Up magazine. Read More.

TOP

News in 2007

December 7, 2007. Wins the Third Annual Faegre & Benson Venture Showcase Award. Read More.

Archive Newsletters (pdf)

January 2010

2009

December 2009

October-November 2009

August-September 2009

June-July 2009

April-May 2009

March 2009

February 2009

January 2009

2008

December 2008

November 2008

TOP